{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:42:29Z","timestamp":1783539749653,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.cgh.2016.11.037","type":"journal-article","created":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T04:33:45Z","timestamp":1482381225000},"page":"850-856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0376-0107","authenticated-orcid":false,"given":"Thomas G.","family":"Cotter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Gathaiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Catania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Edward V.","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Tremaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry M.","family":"Baddour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Scott","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Zinsmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Sandborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H.","family":"Limper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell S.","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2016.11.037_bib1","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1007\/s00436-015-4678-6","article-title":"Pneumocystis jirovecii\u2013from a commensal to pathogen: clinical and diagnostic review","volume":"114","author":"Sokulska","year":"2015","journal-title":"Parasitol Res"},{"key":"10.1016\/j.cgh.2016.11.037_bib2","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2016.11.037_bib3","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/QCO.0b013e32834cac17","article-title":"Pneumocystis jirovecii pneumonia in non-HIV-infected patients: new risks and diagnostic tools","volume":"24","author":"Reid","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cgh.2016.11.037_bib4","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.bjc.6602412","article-title":"An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital","volume":"92","author":"Worth","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cgh.2016.11.037_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy","volume":"71","author":"Yale","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cgh.2016.11.037_bib6","first-page":"1473","article-title":"Immune status and risk for infection in patients receiving chronic immunosuppressive therapy","volume":"32","author":"Gluck","year":"2005","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.cgh.2016.11.037_bib7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1378\/chest.118.3.712","article-title":"Peripheral blood CD4\u00a0+ T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection","volume":"118","author":"Mansharamani","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.cgh.2016.11.037_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00002281-199905000-00004","article-title":"Prevention of infectious complications in rheumatic disease patients: immunization, Pneumocystis carinii prophylaxis, and screening for latent infections","volume":"11","author":"Singer","year":"1999","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.cgh.2016.11.037_bib9","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome","volume":"34","author":"Sepkowitz","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2016.11.037_bib10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/CMR.17.4.770-782.2004","article-title":"Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients","volume":"17","author":"Rodriguez","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cgh.2016.11.037_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.10.1.86","article-title":"Infections in solid-organ transplant recipients","volume":"10","author":"Patel","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cgh.2016.11.037_bib12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3201\/eid1903.121151","article-title":"Increasing Pneumocystis pneumonia, England, UK, 2000-2010","volume":"19","author":"Maini","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cgh.2016.11.037_bib13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/MIB.0b013e3182a827d2","article-title":"Opportunistic infections due to inflammatory bowel disease therapy","volume":"20","author":"Dave","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2016.11.037_bib14","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/ajg.2012.218","article-title":"Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT registry","volume":"107","author":"Lichtenstein","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.11.037_bib15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/bmj.314.7077.363","article-title":"Cyclosporin treatment for ulcerative colitis complicated by fatal Pneumocystis carinii pneumonia","volume":"314","author":"Quan","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2016.11.037_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00054725-200403000-00002","article-title":"Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis","volume":"10","author":"Arts","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2016.11.037_bib17","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.3748\/wjg.15.1897","article-title":"Pneumocystis jiroveci pneumonia and pneumomediastinum in an anti-TNFalpha naive patient with ulcerative colitis","volume":"15","author":"Lee","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.11.037_bib18","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s00535-004-1454-2","article-title":"Pneumocystis carinii pneumonia in patients with ulcerative colitis","volume":"39","author":"Takenaka","year":"2004","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2016.11.037_bib19","first-page":"574","article-title":"Pneumocystis carinii pneumonia in patients with ulcerative colitis treated with corticosteroids","volume":"88","author":"Bernstein","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.11.037_bib20","first-page":"1558","article-title":"An unusual complication of immunosuppressive therapy in inflammatory bowel disease","volume":"92","author":"Khatchatourian","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.11.037_bib21","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00054725-200407000-00017","article-title":"Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's disease","volume":"10","author":"Seddik","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2016.11.037_bib22","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00054725-200409000-00025","article-title":"Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-alpha therapy with infliximab for Crohn's disease","volume":"10","author":"Velayos","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2016.11.037_bib23","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1023\/B:DDAS.0000042246.58984.98","article-title":"Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn's disease","volume":"49","author":"Kaur","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2016.11.037_bib24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ibd.20536","article-title":"Pneumocystis jiroveci (carinii) pneumonia following a second infusion of infliximab in a patient with ulcerative colitis","volume":"15","author":"Estrada","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2016.11.037_bib25","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1007\/s10620-006-9575-5","article-title":"Pneumocystis pneumonia during combined therapy of infliximab, corticosteroid, and azathioprine in a patient with Crohn's disease","volume":"52","author":"Itaba","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2016.11.037_bib26","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s10620-006-9250-x","article-title":"Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases","volume":"52","author":"Kaur","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2016.11.037_bib27","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/MIB.0b013e3182802a9b","article-title":"Increased risk of pneumocystis jiroveci pneumonia among patients with inflammatory bowel disease","volume":"19","author":"Long","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2016.11.037_bib28","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2036.2008.03891.x","article-title":"Oral budesonide for maintenance of remission of Crohn's disease: a\u00a0pooled safety analysis","volume":"29","author":"Lichtenstein","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2016.11.037_bib29","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.4065\/82.9.1052","article-title":"Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials","volume":"82","author":"Green","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cgh.2016.11.037_bib30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2009.727","article-title":"Practice Parameters Committee of the American College of G. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee","volume":"105","author":"Kornbluth","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.11.037_bib31","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1440-1746.2010.06407.x","article-title":"Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience","volume":"25","author":"Lawrance","year":"2010","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2016.11.037_bib32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ibd.20261","article-title":"Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care","volume":"14","author":"Poppers","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2016.11.037_bib33","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","article-title":"Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"8","author":"Rahier","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2016.11.037_bib34","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/MIB.0b013e31828029f4","article-title":"Pneumocystis jiroveci pneumonia in patients with inflammatory bowel disease: a survey of prophylaxis patterns among gastroenterology providers","volume":"19","author":"Okafor","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2016.11.037_bib35","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1007\/s10620-015-3796-4","article-title":"Cost-effectiveness of prophylaxis against Pneumocystis jiroveci pneumonia in patients with Crohn's disease","volume":"60","author":"Okafor","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2016.11.037_bib36","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ibd.20029","article-title":"Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000","volume":"13","author":"Loftus","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2016.11.037_bib37","doi-asserted-by":"crossref","first-page":"S499","DOI":"10.14309\/00000434-201410002-01687","article-title":"Updated incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota (1970-2010)","volume":"109","author":"Shivashankar","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.11.037_bib38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.diagmicrobio.2010.10.021","article-title":"Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificity","volume":"69","author":"Wilson","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cgh.2016.11.037_bib39","unstructured":"US Census Bureau. 2010 Census of Population. Available at:\u00a0http:\/\/www.census.gov\/quickfacts\/chart\/PST045214\/27109. Accessed: May 16,\u00a02016."},{"key":"10.1016\/j.cgh.2016.11.037_bib40","unstructured":"US Census Bureau. 2016. Annual estimates of the resident population: April 1, 2010 to July 1, 2015. Available at: http:\/\/factfinder.census.gov\/faces\/tableservices\/jsf\/pages\/productview.xhtml?src=bkmk. Accessed: May 16,\u00a02016."},{"key":"10.1016\/j.cgh.2016.11.037_bib41","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/gut.2006.105890","article-title":"The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota","volume":"56","author":"Pardi","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2016.11.037_bib42","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mayocp.2011.11.009","article-title":"Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project","volume":"87","author":"St Sauver","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cgh.2016.11.037_bib43","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/ije\/dys195","article-title":"Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system","volume":"41","author":"St Sauver","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.cgh.2016.11.037_bib44","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/aje\/kwq482","article-title":"Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project","volume":"173","author":"St Sauver","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cgh.2016.11.037_bib45","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1503\/cmaj.111152","article-title":"Considerations when prescribing trimethoprim-sulfamethoxazole","volume":"183","author":"Ho","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.cgh.2016.11.037_bib46","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/j.1875-9114.1995.tb04378.x","article-title":"A\u00a0large population-based follow-up study of trimethoprim-sulfamethoxazole, trimethoprim, and cephalexin for uncommon serious drug toxicity","volume":"15","author":"Jick","year":"1995","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cgh.2016.11.037_bib47","doi-asserted-by":"crossref","first-page":"e1001058","DOI":"10.1371\/journal.ppat.1001058","article-title":"Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia","volume":"6","author":"Wang","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cgh.2016.11.037_bib48","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1099\/jmm.0.45528-0","article-title":"Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens","volume":"53","author":"Flori","year":"2004","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.cgh.2016.11.037_bib49","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jaad.2009.11.588","article-title":"Role of primary prophylaxis for pneumocystis pneumonia in patients treated with systemic corticosteroids or other immunosuppressive agents for immune-mediated dermatologic conditions","volume":"63","author":"Lehman","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356516312332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356516312332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:23:46Z","timestamp":1761542626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356516312332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1542356516312332"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2016.11.037","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2016.11.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the AGA Institute","name":"copyright","label":"Copyright"}]}}